82 related articles for article (PubMed ID: 31372035)
1. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation.
Kumar T; Schernberg A; Busato F; Laurans M; Fumagalli I; Dumas I; Deutsch E; Haie-Meder C; Chargari C
Cancer Manag Res; 2019; 11():6285-6297. PubMed ID: 31372035
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric correlation of bone marrow irradiation with acute hematological toxicity in concurrent chemoradiation of cervical carcinoma patients.
Pruthi DS; Nagpal P; Pandey M; Singh H
Indian J Cancer; 2023; 60(3):432-438. PubMed ID: 36861701
[TBL] [Abstract][Full Text] [Related]
3. A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer.
Chen H; Zhong Q; Liu Y; Li J; Deng W; Wang J; Zhou S; Yu Z; Huang X; Huang Y; Zhen B; Wei J; Zhang W; Ruan X; Xiao L
Radiat Oncol; 2023 Nov; 18(1):193. PubMed ID: 38012675
[TBL] [Abstract][Full Text] [Related]
4. Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
Li W; Ma L; Li F; Li K; Zhang Y; Ren H; Bao X; Guo Y; Guo Y; Wang M; Li D; Duan Y; Ma X; Wang Z; Wang Y; Yin R
Radiat Oncol; 2024 Apr; 19(1):46. PubMed ID: 38594678
[TBL] [Abstract][Full Text] [Related]
5. Dose-Volume Parameters of Spared Magnetic Resonance Imaging-Defined Active Bone Marrow Predict Hematologic Toxicity in Pelvic Malignancies Patients Undergoing Radiotherapy: A Cohort Study.
Gao T; Wei L; Jiang L; Ma S; Zhang W; Zhang Y; Wu F
Technol Cancer Res Treat; 2024; 23():15330338241255283. PubMed ID: 38752234
[No Abstract] [Full Text] [Related]
6. Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity.
Zhang A; Deek MP; Kim S; Sayan M; Grann A; Wagman RT; Malhotra U; Hathout L; Biswal N; Zhang Y; Langenfeld J; Kennedy T; August DA; Jabbour SK
J Gastrointest Oncol; 2019 Jun; 10(3):513-522. PubMed ID: 31183202
[TBL] [Abstract][Full Text] [Related]
7. Prediction Factors of Radiation Esophagitis in Breast Cancer Patients Undergoing Supraclavicular Radiotherapy.
Amin SSM; Faraj KA; Ali JS; Rahim HAH; Yarahmadi M
J Med Phys; 2023; 48(1):38-42. PubMed ID: 37342603
[TBL] [Abstract][Full Text] [Related]
8. Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?
Yue H; Li X; You J; Feng P; Du Y; Wang R; Wu H; Cheng J; Ding K; Jing B
Front Oncol; 2024; 14():1365897. PubMed ID: 38835389
[TBL] [Abstract][Full Text] [Related]
9. Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer.
Teng Y; Ma D; Yan Y; Geng J; Liu Z; Zhu X; Li S; Zhang Y; Wang H; Cai Y; Yue H; Li Y; Wang W
Front Oncol; 2023; 13():1289824. PubMed ID: 38230393
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy.
Vitzthum LK; Heide ES; Park H; Williamson CW; Sheridan P; Huynh-Le MP; Sirak I; Wei L; Tarnawski R; Mahantshetty U; Nguyen C; Mayadev J; Yashar CM; Sacco AG; Mell LK
Front Oncol; 2020; 10():1179. PubMed ID: 32793487
[No Abstract] [Full Text] [Related]
11. Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer.
Kuncman Ł; Stawiski K; Masłowski M; Kucharz J; Fijuth J
Strahlenther Onkol; 2020 Nov; 196(11):998-1005. PubMed ID: 32621010
[TBL] [Abstract][Full Text] [Related]
12. Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial.
Huang J; Gu F; Ji T; Zhao J; Li G
Radiat Oncol; 2020 Jul; 15(1):180. PubMed ID: 32727497
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy.
Huang W; Dang J; Li Y; Cui HX; Lu WL; Jiang QF
Front Oncol; 2021; 11():646211. PubMed ID: 33968746
[TBL] [Abstract][Full Text] [Related]
14. Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.
Konnerth D; Gaasch A; Zinn A; Rogowski P; Rottler M; Walter F; Knoth J; Sturdza A; Oelmann J; Grawe F; Bodensohn R; Belka C; Corradini S
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791920
[TBL] [Abstract][Full Text] [Related]
15. The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis.
Kuipers S; Godart J; Corbeau A; Sharfo AW; Breedveld S; Mens JW; de Boer S; Nout R; Hoogeman M
Front Oncol; 2023; 13():1138433. PubMed ID: 37448523
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiation-induced hematological toxicity and related vertebral dosimetry evaluations in patients with locally advanced gastric cancer: data from a phase III clinical trial.
Wang JJ; Shao H; Zhang L; Jing M; Xu WJ; Sun HW; Zhou ZW; Zhang YJ
Radiat Oncol; 2023 Jun; 18(1):100. PubMed ID: 37365597
[TBL] [Abstract][Full Text] [Related]
17. The effect of radiotherapy time and dose on acute hematologic toxicity during concurrent postoperative chemoradiotherapy for early high-risk cervical cancer.
Yang X; Li Z; Zhang L; Li H; Yang X; Sun Y; Liu L; Fu J
J Cancer; 2023; 14(6):895-902. PubMed ID: 37151393
[No Abstract] [Full Text] [Related]
18. Dose estimation for cone-beam computed tomography in image-guided radiation therapy for pelvic cancer using adult mesh-type reference computational phantoms.
Cumur C; Fujibuchi T; Arakawa H; Hamada K
Radiol Phys Technol; 2023 Jun; 16(2):203-211. PubMed ID: 36877400
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
